期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

复发/难治性多发性骨髓瘤的治疗进展 被引量：3

下载PDF
导出
摘要 复发/难治性多发性骨髓瘤(MM)患者中位生存期短,治疗有效期维持时间短,目前尚无有效的治疗手段。新药如来那度胺、沙利度胺及硼替佐米等单药治疗与常规化疗药物联合治疗本病是当前研究的热点。
作者 朱蓉 侯健
机构地区 第二军医大学长征医院血液科
出处 《世界临床药物》 CAS 2008年第5期273-276,299,共5页 World Clinical Drug
关键词 复发/难治性多发性骨髓瘤 硼替佐米 沙利度胺 来那度胺
分类号 R551.3 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献10

  • 1Richardson PG,Sonneveld P,Schuster M,et al.Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial[].Blood.2007
  • 2Palumbo A,Gay F,Bringhen S,et al.Bortezomib,doxoru- bicin and dexamethasone in advanced multiple myeloma[].Annals of Oncology.2008
  • 3Palumbo A,Ambrosini MT,Benevolo G,et al.Bortezomib, melphalan,prednisone,and thalidomide for relapsed multiple myeloma[].Blood.2007
  • 4Palumbo A,Avonto I,Bruno B,et al.Intermediate-dose melp- halan(100 mg/m2)/bortezomib/thalidomide/dexamethasone and stem cell support in patients with refractory or relapsed myeloma[].Clin Lymphoma Myeloma.2006
  • 5Richardson P,Mitsiades C,Colson K,et al.PhaseⅠtrial of oral vorinostat(suberoylanilide hydroxamic acid,SAHA)in patients with advanced multiple myeloma[].Leukemia and Lymphoma.2008
  • 6Dimopoulos MA,Hamilos G,Zomas A,et al.Pulsed cycl- ophosphamide,thalidomide and dexamethasone:an oral regimen for previously treated patients with multiple myeloma[].Hematol Journal.2004
  • 7Offidani M,Corvatta L,Marconi M,et al.Low-dose thalido- mide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective,multicenter,phaseⅡstudy[].Haematologica.2006
  • 8Dimopoulos M,Spencer A,Attal M,et al.Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma[].The New England Journal of Medicine.2007
  • 9Knight R,DeLap RJ,Zeldis JB.Lenalidomide and venous thrombosis in multiple myeloma[].The New England Journal of Medicine.2006
  • 10Richardson PG,Sonneveld P,Schuster MW,et al.Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma[].British Journal of Haematology.2007

同被引文献21

  • 1王顺清,毛平,李庆山,应逸,莫文健,许艳丽,王汉平,杜庆华,谢健晋.非清髓性造血干细胞移植加供者淋巴细胞输注治疗多发性骨髓瘤1例报告并文献复习*[J].临床血液学杂志,2005,18(2):75-78. 被引量：3
  • 2袁振刚,侯健,周帆,王东星,付卫军,陈玉宝,奚昊,杨盛玲.硼替佐米联合地塞米松治疗16例复发、难治性多发性骨髓瘤患者[J].中华血液学杂志,2006,27(10):653-655. 被引量：21
  • 3翟勇平,刘海宁,于亚平,宋萍,周晓钢,李锋,王学文.BLTD方案治疗24例难治复发性多发性骨髓瘤[J].中华血液学杂志,2007,28(4):270-271. 被引量：5
  • 4Palumbo A, Bertola A, Falco P, et al. Efficacy of low-dose thalidomide and dexamethasone as fist salvage regimen in multiple myltipie myelome [ J ]. Hematol J,2004,5 (4) :318-324.
  • 5Barlogie B, Kyle RA, Anderson KC, et al. Standard chemotherapy compared with high-dose ehemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321 [ J]. J Clin Oncol,2006,24(6) :929-936.
  • 6Dimopaulos MA, Zervas K, Kouvaseas G, et al. Thalidomide and dexamethasone combination for refractory multiole my cloma[J]. Ann Oncol, 2001,12(7) : 991-995.
  • 7Badros A,Goloubeva O, Dalal JS, et al. Neurotoxicity of borte- zomib therapy in multiple myeloma: a single- center experi- ence and review of the literature [J]. Cancer, 2007, 110 (5): 1042-1049.
  • 8Colson K, Doss DS, Swift R, et al. Expanding role of borte- zomib in multiple myeloma: nursing implications [J]. Cancer Nurs,2008,31(3) :239-249.
  • 9Orlowski RT_agler A,Sonneveld Pet al.RandomizedphaselII study of pegylated liposo- real doxorubiein plusbortezomib compared with bortezomib alone in relapsedor refrac- tory multiple mye|oma:eombination therapyimproves time to progression[J].CIinOneol, 2007,25'3892-3901.
  • 10Kumar SK,Rajkumar SV,l)ispenziefi A,et al.Impmved survival inmultiple myeloma and the impact of novel therapeies[J].Blood,2008,111(5)'.2516-2520.

引证文献3

二级引证文献10

世界临床药物
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部